Is Nath Bio-Genes India the Best Stock in Its Sector? A Look at the Numbers

Nath Bio-Genes India CMP Rs 139 (01 Oct 2026). Market cap Rs 272 Cr. ROE 5.32%. P/E 7.02x versus Industry P/E 34.63x.

Is Nath Bio-Genes India the best stock in its sector? The stock trades on the NSE at Rs 139 as of 01 October 2026, within its 52-week range of Rs 126.15 to Rs 204.00. Nath Bio-Genes (India) Ltd manufactures hybrid seeds for cotton and other crops.

Nath Bio-Genes India sits in the Agri sector, and its 5.32% ROE and 7.02x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Nath Bio-Genes India

Nath Bio-Genes (India) Ltd manufactures hybrid seeds for cotton and other crops. The stock fell close to 3 percent during this session, well below its 52-week high. At a market capitalisation of Rs 272 Cr, it is tracked as part of the Agri sector on Univest.

Is Nath Bio-Genes India the Best Stock in Its Sector?

Nath Bio-Genes India makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 5.32% ROE with a 7.02x P/E against the sector’s 34.63x Industry P/E. Nath Bio-Genes India’s 7.02x P/E is far below the 34.63x Industry P/E and it trades well under book value, but a 5.32% ROE is modest, so the discount reflects thinner current returns as much as an overlooked opportunity.

Compare Nath Bio-Genes India Against Other Agri Sector Stocks

How Nath Bio-Genes India Compares Against Its Agri Sector Peers

The table below sets Nath Bio-Genes India against 2 other Agri sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Against this peer set, Nath Bio-Genes India’s 5.32% ROE is below the 12.54% peer average, and its P/E of 7.02x runs below the peer average of 14.71x. Nath Bio-Genes India’s 7.02x P/E is far below the 34.63x Industry P/E and it trades well under book value, but a 5.32% ROE is modest, so the discount reflects thinner current returns as much as an overlooked opportunity.

What Makes Nath Bio-Genes India Worth Watching in Agri

• Well below book value and Industry P/E: A 7.02x P/E against a 34.63x Industry P/E, alongside a P/B of 0.40, means the stock trades well under its own book value.
• Low leverage, dividend yield: A debt to equity ratio of 0.20 is comfortable, and a 1.40% dividend yield adds a modest income component.
• Hybrid seed manufacturing scale: Manufacturing hybrid seeds for cotton and other crops gives Nath Bio-Genes a position in India’s agricultural inputs industry.

Nath Bio-Genes India Valuation: Is It Justified?

Nath Bio-Genes India’s 7.02x P/E is far below the 34.63x Industry P/E and it trades well under book value, but a 5.32% ROE is modest, so the discount reflects thinner current returns as much as an overlooked opportunity. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is Motisons Jewellers the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Nath Bio-Genes India and other Agri sector stocks.

How to Track Nath Bio-Genes India Before You Invest

Before deciding whether Nath Bio-Genes India deserves its label as the best stock in its sector for your own portfolio, compare it directly against Agri sector peers using the steps below.

1. Open the Univest Screener and search for Nath Bio-Genes India to view live price, valuation ratios, and peer comparisons within the Agri sector.
2. Compare its P/E, P/B, and ROE against other Agri sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Nath Bio-Genes India earns a place in the best stock in its sector conversation on the strength of a 5.32% ROE and a P/E of 7.02x against a 34.63x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is Nath Bio-Genes India the best stock in its sector?

Ans. Nath Bio-Genes India has a 5.32% ROE and trades at 7.02x P/E against a 34.63x Industry P/E, and compares below the peer average ROE of 12.54% in this article’s named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Nath Bio-Genes India?

Ans. Nath Bio-Genes India was trading at Rs 138.52 on the NSE as of 01 October 2026, within its 52-week range of Rs 126.15 to Rs 204.00.

What sector does Nath Bio-Genes India belong to?

Ans. Nath Bio-Genes India is classified under the Agri sector on Univest.

How does Nath Bio-Genes India compare to its sector peers on P/E?

Ans. Nath Bio-Genes India’s P/E of 7.02x is below the 14.71x average of the 2 named peers compared in this article.

What is Nath Bio-Genes India’s return on equity?

Ans. Nath Bio-Genes India reported a return on equity of 5.32%, which is below the 12.54% average of its named peers in this comparison.

Should I invest in Nath Bio-Genes India based on its sector position?

Ans. Nath Bio-Genes India’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “Is Nath Bio-Genes India the best stock in its sector?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India has a 5.32% ROE and trades at 7.02x P/E against a 34.63x Industry P/E, and compares below the peer average ROE of 12.54% in this article’s named comparison, so the answer depends on what an investor is prioritising.”}}, {“@type”: “Question”, “name”: “What is the current share price of Nath Bio-Genes India?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India was trading at Rs 138.52 on the NSE as of 01 October 2026, within its 52-week range of Rs 126.15 to Rs 204.00.”}}, {“@type”: “Question”, “name”: “What sector does Nath Bio-Genes India belong to?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India is classified under the Agri sector on Univest.”}}, {“@type”: “Question”, “name”: “How does Nath Bio-Genes India compare to its sector peers on P/E?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India’s P/E of 7.02x is below the 14.71x average of the 2 named peers compared in this article.”}}, {“@type”: “Question”, “name”: “What is Nath Bio-Genes India’s return on equity?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India reported a return on equity of 5.32%, which is below the 12.54% average of its named peers in this comparison.”}}, {“@type”: “Question”, “name”: “Should I invest in Nath Bio-Genes India based on its sector position?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Nath Bio-Genes India’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.”}}]}